PharmiWeb.com - Global Pharma News & Resources
19-Dec-2018

Global Optic Neuritis - API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 - ResearchAndMarkets.com

The "Optic Neuritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

The 'Optic Neuritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018' report provides comprehensive insights about marketed and Phase III products for Optic Neuritis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country.

Global API Manufacturers of Marketed Products for Optic Neuritis

Coverage of API manufacturers for Optic Neuritis marketed products spanning across United States, Europe, China and India. The manufacturers' details include manufacturers' name along with their location.

Emerging Phase III products for Optic Neuritis

This report provides a comprehensive understanding of the emerging Phase III therapies for Optic Neuritis which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.

Key Topics Covered:

1. Report Introduction

2. Optic Neuritis: Overview

  • Risk Factors
  • Causes
  • Symptoms
  • Pathophysiology
  • Prognosis
  • Diagnosis
  • Treatment

3. Comparative Analysis of Marketed and Emerging Products

4. Marketed Therapies

  • Product Description
  • Route of Synthesis
  • Mechanism of Action
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Adverse Reactions
  • Clinical Trials
  • Regulatory Milestones
  • Product Development Activities
  • United States
  • Europe
  • Historical Global Sales
  • Forecasted Global Sales

5. Emerging Therapies (Phase III)

  • Product Description
  • Research and Development
  • Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/phvzpz/global_optic?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181219005258/en/

Editor Details

Last Updated: 19-Dec-2018